Key result
EEG monitoring in neonates with complex CHD is linked to ~4-fold higher seizure detection.
Why the study?
Neonates with complex congenital heart disease face an increased risk for perioperative brain injury and seizures, yet national electroencephalography utilization patterns remain poorly characterized.
Does electroencephalography monitoring improve seizure detection and affect length of stay and hospitalization costs in neonates with complex congenital heart disease undergoing surgical repair or palliation?
Cohort (n=13,202)
Yes
Does electroencephalography monitoring improve seizure detection and affect length of stay and hospitalization costs in neonates with complex congenital heart disease undergoing surgical repair or palliation?
Answers are grounded in this paper and cite their sources.
EEG utilization in neonates undergoing surgery for complex congenital heart disease is increasing over time in the US, though it remains low (12.5%) and highly variable across hospitals (0% to >40%), highlighting the need for standardized neurologic monitoring protocols.
Background Neonates with complex congenital heart disease are at increased risk for perioperative brain injury and seizures. Electroencephalography (EEG) detects clinical and subclinical seizures, but national utilization patterns remain poorly characterized. Methods We conducted a retrospective cohort study using the Pediatric Health Information System (2016–2025) of neonates ≤28 days with dextro‐transposition of the great arteries or single‐ventricle physiology undergoing surgical repair or palliation. Mixed‐effects logistic regression with hospital as a random effect identified predictors of EEG utilization. Results Among 13 202 neonates, 1654 (12.5%) underwent EEG monitoring. EEG monitoring was performed in only 10.8% of neonates with dextro‐transposition of the great arteries, 16% of those with hypoplastic left heart syndrome, and 13% of those with non‐ hypoplastic left heart syndrome single‐ventricle lesions. EEG utilization increased from ~6% in 2016 to >14% in 2025, while seizure detection among EEG‐monitored patients increased from 13% to ~26% (both P ‐trend<0.01). Utilization varied substantially across hospitals (0% to >40%), persisting after adjustment for surgical volume. EEG‐monitored neonates had higher seizure detection (21.8% versus 5.2%), longer length of stay (33 versus 24 days), and higher hospitalization costs ($344 719 versus $174 865; all P <0.01). In multivariable analysis, EEG utilization was independently associated with seizures (OR ~4), dextro‐transposition of the great arteries, and hypoplastic left heart syndrome, but not with cardiac arrest, extracorporeal membrane oxygenation, or hypoxic‐ischemic encephalopathy. Conclusions EEG utilization in neonates with complex congenital heart disease is increasing but remains low and highly variable across US centers. The association of EEG use with higher mortality and costs may reflect confounding by indication or illness severity. Standardized protocols are needed to optimize neurologic monitoring and improve long‐term outcomes.
No takes yet. Share an insight, caveat, or question.
Aly et al. (2026) conducted a cohort in Complex congenital heart disease (dextro-transposition of the great arteries or single-ventricle physiology) (n=13,202). Electroencephalography (EEG) monitoring vs. No EEG monitoring was evaluated on Seizure detection (OR ~4, p=<0.01). Electroencephalography monitoring occurred in 12.5% of neonates with complex CHD and was associated with higher seizure detection and longer hospital stays (33 vs 24 days).
Synapse has enriched 10 related papers. Consider them for comparative context: